These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 20854235)

  • 21. ADVANCE: lessons from the run-in phase of a large study in type 2 diabetes.
    Perkovic V; Joshi R; Patel A; Bompoint S; Chalmers J;
    Blood Press; 2006; 15(6):340-6. PubMed ID: 17472024
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Perindopril + indapamide: new preparation. Simple trick.
    Prescrire Int; 1999 Dec; 8(44):172-5. PubMed ID: 11503814
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A systematic review and meta-analysis of the efficacy and safety of a fixed, low-dose perindopril-indapamide combination as first-line treatment of hypertension.
    Kang S; Wu YF; An N; Ren M
    Clin Ther; 2004 Feb; 26(2):257-70. PubMed ID: 15038948
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Perindopril/indapamide 2/0.625 mg/day: a review of its place in the management of hypertension.
    Matheson AJ; Cheer SM; Goa KL
    Drugs; 2001; 61(8):1211-29. PubMed ID: 11465878
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Efficacy and safety of fixed combination of perindopril and indapamide in type 2 diabetes: results from ADVANCE in context of available evidence.
    Chalmers J; Joshi R; Kengne AP; Ninomiya T; Bi Y; Bompoint S; Billot L; Patel A;
    J Hypertens Suppl; 2008 Sep; 26(3):S21-7. PubMed ID: 19363849
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Evaluation of high dose of perindopril/indapamide fixed combination in reducing blood pressure and improving end-organ protection in hypertensive patients.
    Mourad JJ; Le Jeune S
    Curr Med Res Opin; 2009 Sep; 25(9):2271-80. PubMed ID: 19627177
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Blood pressure control and acceptability of perindopril and its fixed dose combinations with amlodipine or indapamide, in younger patients with hypertension.
    Bansal S; Chauhan DK; Ramesh D; Barmare S; Chakraborty S
    Indian Heart J; 2014; 66(6):635-9. PubMed ID: 25634398
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Blood pressure lowering with fixed combination perindopril-indapamide: key findings from ADVANCE.
    Chalmers J; Joshi R; Kengne AP; MacMahon S
    J Hypertens Suppl; 2008 Jun; 26(2):S11-5. PubMed ID: 18979718
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Protection of patients with diabetes, with or without hypertension: implications of ADVANCE for clinical practice.
    Mancia G; Grassi G
    J Hypertens Suppl; 2009 May; 27(1):S19-23. PubMed ID: 19483504
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Regression of left ventricular mass in hypertensive patients treated with perindopril/indapamide as a first-line combination: the REASON echocardiography study.
    de Luca N; Mallion JM; O'Rourke MF; O'Brien E; Rahn KH; Trimarco B; Romero R; De Leeuw PW; Hitzenberger G; Battegay E; Duprez D; Sever P; Safar ME
    Am J Hypertens; 2004 Aug; 17(8):660-7. PubMed ID: 15323062
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effect of low-dose perindopril/indapamide on albuminuria in diabetes: preterax in albuminuria regression: PREMIER.
    Mogensen CE; Viberti G; Halimi S; Ritz E; Ruilope L; Jermendy G; Widimsky J; Sareli P; Taton J; Rull J; Erdogan G; De Leeuw PW; Ribeiro A; Sanchez R; Mechmeche R; Nolan J; Sirotiakova J; Hamani A; Scheen A; Hess B; Luger A; Thomas SM;
    Hypertension; 2003 May; 41(5):1063-71. PubMed ID: 12654706
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Nephroprotection diabetes mellitus type 2: lessons from the ADVANCE trial].
    Nedogoda SV
    Kardiologiia; 2011; 51(12):57-9. PubMed ID: 22304318
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Vascular legacy beyond blood pressure control: benefits of perindopril/indapamide combination in hypertensive patients with diabetes.
    Lévy BI; Taddei S
    Curr Med Res Opin; 2018 Sep; 34(9):1557-1570. PubMed ID: 29307229
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Evaluation of the antihypertensive efficacy and tolerability of fixed very low-dose perindopril/indapamid combination in patients with mild to moderate hypertension. Results of a Czech and Slovak multicentric study].
    Widimský J; Fedelesová V
    Vnitr Lek; 2004 Jun; 50(6):447-52. PubMed ID: 15346638
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Implications of the ADVANCE study for clinical practice.
    Zannad F
    J Hypertens Suppl; 2008 Sep; 26(3):S29-32. PubMed ID: 19363850
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Low-dose fixed combination of perindopril plus indapamide in the diabetic hypertensive population.
    Barrios V; Escobar C; Divison JA; Medialdea F
    Expert Rev Cardiovasc Ther; 2008 Sep; 6(8):1063-9. PubMed ID: 18793109
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Lowering blood pressure reduces renal events in type 2 diabetes.
    de Galan BE; Perkovic V; Ninomiya T; Pillai A; Patel A; Cass A; Neal B; Poulter N; Harrap S; Mogensen CE; Cooper M; Marre M; Williams B; Hamet P; Mancia G; Woodward M; Glasziou P; Grobbee DE; MacMahon S; Chalmers J;
    J Am Soc Nephrol; 2009 Apr; 20(4):883-92. PubMed ID: 19225038
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Risks of cardiovascular events and effects of routine blood pressure lowering among patients with type 2 diabetes and atrial fibrillation: results of the ADVANCE study.
    Du X; Ninomiya T; de Galan B; Abadir E; Chalmers J; Pillai A; Woodward M; Cooper M; Harrap S; Hamet P; Poulter N; Lip GY; Patel A;
    Eur Heart J; 2009 May; 30(9):1128-35. PubMed ID: 19282274
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Combined effects of routine blood pressure lowering and intensive glucose control on macrovascular and microvascular outcomes in patients with type 2 diabetes: New results from the ADVANCE trial.
    Zoungas S; de Galan BE; Ninomiya T; Grobbee D; Hamet P; Heller S; MacMahon S; Marre M; Neal B; Patel A; Woodward M; Chalmers J; ; Cass A; Glasziou P; Harrap S; Lisheng L; Mancia G; Pillai A; Poulter N; Perkovic V; Travert F
    Diabetes Care; 2009 Nov; 32(11):2068-74. PubMed ID: 19651921
    [TBL] [Abstract][Full Text] [Related]  

  • 40. An economic evaluation of a perindopril-based blood pressure lowering regimen for patients who have suffered a cerebrovascular event.
    Tavakoli M; Pumford N; Woodward M; Doney A; Chalmers J; MacMahon S; Macwalter R
    Eur J Health Econ; 2009 Feb; 10(1):111-9. PubMed ID: 18446392
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.